GlobeNewswire

CompactCath Expands Product Portfolio with New Discreet Straight and Coudé Intermittent Catheters

Del

Products welcome added relief for everyday self-catheterizing users

PALO ALTO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- CompactCath (www.compactcath.com), a medical device company committed to improving the quality of life for people with bladder conditions, has announced the expansion of its intermittent urinary catheter product line with the addition of CompactCath® Coudé and OneCath®. The new CE and FDA approved devices will be available from various distributors, wholesalers, and directly at www.compactcath.com.

 “Since launching the CompactCath brand, we’ve received overwhelming positive feedback from both users and clinicians, citing the catheter’s non-touch insertion, discreetness, portability, and convenience as revolutionary in comparison to current catheters available in the marketplace,” said Naama Stauber Breckler, CEO of CompactCath. “We have also found that in addition to compact catheter solutions for active lifestyles, there is a rising need for affordable catheters that don't sacrifice quality for cost, especially for the uninsured, underinsured, and those with high deductibles, and that’s why we created OneCath®.”

OneCath® has been introduced as the perfect complement to the CompactCath intermittent urinary catheter line. Available in both a straight and coudé tip in pediatric and adult sizes, OneCath® is a high quality catheter at an affordable price point, designed to improve the lives of patients and help in an industry with continuously rising healthcare costs. CompactCath is committed to eliminating the use of known carcinogens in the medical market place, and its products are 100% DEHP, BPA, and Rubber Latex free.

CompactCath® Coudé combines the compact design of CompactCath®, providing a smaller, easy to use, and discreet catheterization experience unlike traditional catheters. It is the only, pocket sized 16” long catheter with a coudé tip that fits in the palm of the hand and features a 100% non-touch system, fire-polished eyelets, silicone oil lubrication, and drainage control. CompactCath® Coudé is a welcome addition to the company’s product line, increasing the reach for those who require a curved tip to successfully drain their bladder. CompactCath® Coudé was designed for easier insertion and is the first of its kind to feature the unique “Case Up, Tip Up” design, which simplifies the catheterization process by reducing the need for visual dependency.

“With traditional coudé catheters, it’s difficult to know whether the tip is pointing in the right direction, which is crucial for proper insertion,” said Dr. Daniel Hong, CompactCath’s Chief Medical Officer. “We’ve alleviated this problem by simplifying the design of the catheter. As long as CompactCath® Coudé is held in the vertical position, the tip will also be in the vertical, upright position, allowing for correct insertion and removal throughout the catheterization process. This creates a manageable and controllable procedure by greatly reducing discomfort and the risk of catheter associated trauma to the urethra. We have invented the first catheter which eliminates the need for a guide stripe as we commonly see on coudé catheters, simplifying the insertion process and allowing users to catheterize correctly and with confidence.”

The CompactCath line now has products to fit all lifestyles and budgets, and features the following:

  • CompactCath®, ready to use, compact pocket-sized catheter
  • OneCath®, high quality catheter at an affordable price point for the underinsured and those with high deductibles
  • 100% smooth, fire-polished eyelets
  • DEHP, BPA, and Rubber Latex Free
  • User-friendly design
  • Available in straight and coudé tips in a variety of sizes for men and women
  • Available through distributors and wholesalers nationwide
  • Reimbursed by Medicare, Medicaid, and most private insurances

Along with its product expansion, CompactCath is also focused on expanding its marketing and brand awareness campaign to reach catheter users and clinicians. The company will be supporting its products with its first ever above the line advertising direct-to-consumer campaign featuring dedicated TV spots, trade shows and magazine placements to increase the reach of consumers who can benefit from these new product additions. The expanded product line will debut at the 48th Annual Meeting of the International Continence Society in Philadelphia on August 28-31, 2018.

About CompactCath  
CompactCath is committed to improving the quality of life for those who suffer from bladder conditions and need to self-catheterize. CompactCath is composed of a multidisciplinary team of physicians, engineers, and catheter users who share a passion for healthcare, design, and comfort. Established in 2012 at Stanford University, CompactCath is driven by the goal to design medical devices that enable those with chronic conditions to lead active, thriving, independent lives.

Press Contact: Carlos Wilson (carloswilson@tandemcomms.com)
845.242.4440

Photos accompanying this announcement are available at:

http://www.globenewswire.com/NewsRoom/AttachmentNg/0cd1f2ba-05e8-498c-8265-ee8dae2a9e9e

http://www.globenewswire.com/NewsRoom/AttachmentNg/6b6929dc-53a4-4acc-b981-0145486f4854

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies24.6.2019 23:30:00 CESTPressemelding

LYON, France and CAMBRIDGE, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (ERYTECH) (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells (RBCs), announced today that it has entered into an agreement with SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments in multiple therapeutic areas, to advance novel RBC-based therapeutics for immune modulation . Under the terms of the agreement, ERYTECH has granted to SQZ an exclusive worldwide license to develop antigen-specific immune modulating therapies employing RBC-based approaches. Combining SQZ’s proprietary and versatile cell engineering platform, Cell Squeeze®, with ERYTECH’s intellectual property related to RBC-based therapeutics is intended to allow for the rapid development of a broad pipeline of novel immunomodulatory products addressing multiple indications. ERYTECH is eligible to rec

Forterra Announces Leadership Appointments24.6.2019 22:24:00 CESTPressemelding

Construction Materials Veteran Karl H. Watson, Jr. Named Chief Executive Officer Forterra Board Member John McPherson Appointed Lead Director and Vice Chairman of the Board Company Reaffirms Full Year 2019 Outlook IRVING, Texas, June 24, 2019 (GLOBE NEWSWIRE) -- Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ:FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced that Karl H. Watson, Jr. has been appointed Chief Executive Officer and a member of the Forterra Board of Directors. Mr. Watson succeeds Jeff Bradley, who has stepped down as CEO and a director to pursue other opportunities. Mr. Watson brings over 30 years of global experience in the construction materials industry and a track record of effectively leading through numerous business cycles and improving financial and operational results. He most recently served as Executive Vice President and Chief Operating Officer at Summit Materials,

Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman24.6.2019 17:35:00 CESTPressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors. The current Chairman, Mr. Richard A. Sandberg, will remain a member of the board. “On behalf of the Company and the board of directors I would like to thank our former Chairman, Richard Sandberg, for his service,” said Dr. Peter Wrighton-Smith, CEO of Oxford Immunotec. “In the decade that he served as Chairman, the Company has undergone a profound transformation, and Mr. Sandberg’s guidance and leadership has made an extraordinary contribution to Oxford Immunotec’s success. We look forward to continuing to benefit from his skills and his knowledge of the Company with his ongoing service as a Non-Executive Director.” “We are very pleased to have Mr. Balthrop assume the role of Chairman,” continued Dr. Wrigh

Woodbridge by Robert Mondavi Announces New Transformative Brand Positioning24.6.2019 15:50:00 CESTPressemelding

“From One For All” National Campaign Brings Brand’s Pioneering Spirit to the Forefront of Story and Marks a Number of Brand Firsts LODI, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Woodbridge by Robert Mondavi, the number-three wine brand in the United States* with 40 years of history dedicated to raising the standard for everyday wines in America and globally, announces a new milestone with the launch of its new national brand campaign. The “From One For All” campaign celebrates Woodbridge founder Robert Mondavi’s pivotal role in democratizing wine. It is supported by a 360-degree integrated marketing plan backed by the largest investment in the brand’s history. For the first time, Woodbridge by Robert Mondavi tells the winery’s powerful founding story and industry-changing vision through the lens of its iconic founder Robert Mondavi in the new “From One For All” marketing campaign. Celebrated for his achievements helping to establish California’s reputation for fine winemaking on a glo

Sanan IC Expands Wafer Foundry Portfolio for Power Electronics with 150mm GaN-on-Silicon Process24.6.2019 15:00:00 CESTPressemelding

SUNNYVALE, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- SANAN INTEGRATED CIRCUIT CO., LTD. (Sanan IC), a pure-play wafer foundry with its advanced compound semiconductor technology platform, today announced the commercial release of its 150mm gallium nitride (GaN) on silicon wafer foundry services intended for the latest high voltage AC/DC and DC/AC power electronics applications in the global market. Sanan IC’s new G06P111 is a 650V enhanced-mode high-electron-mobility transistor (E-HEMT) GaN process which adds to the company’s power electronics wafer foundry portfolio of wide bandgap (WBG) compound semiconductors that includes 100mm and 150mm silicon carbide (SiC) for high voltage Schottky Barrier Diodes (SBD). Leveraging years of high volume GaN manufacturing experience by Sanan Optoelectronics Inc., its parent company, for the LED market, Sanan IC is able to complement its foundry services with in-house MOCVD growth capabilities of high voltage, low leakage GaN-on-silicon epitaxial wa

Nasdaq Promotes Tal Cohen to Executive Vice President, North American Market Services24.6.2019 14:30:00 CESTPressemelding

Tom Wittman to become Executive Advisor and to retire from Nasdaq at year-end NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. today announced it has named Tal Cohen as Executive Vice President, North American Market Services, effective July 1. In this role, Cohen will be responsible for driving the strategy and success of our trading businesses across cash equities, commodities, derivatives, and trade management services in Nasdaq’s U.S. and Canadian markets. In his role, in addition to directing the strategy of the business, Cohen will oversee Nasdaq’s North American trading products across their lifecycle and will manage client relationships and market operations. He will report to Adena Friedman, President and CEO, Nasdaq. Cohen joined Nasdaq in April 2016 as Senior Vice President of North American Equities following the acquisition of Chi-X Canada, where he had served as CEO of Chi-X Global Holdings for six years. Prior to Chi-X, Cohen held senior positions at Instinet, Am